Head-to-Head Comparison

Doximity vs Glass Health: Which Is Better for Physicians?

Doximity ranks #4 in our 2026 clinical decision support rankings with a 3.5-star editorial rating, while Glass Health ranks #5 with a 3.5-star editorial rating. Ratings are calculated from our published criteria. No single tool wins every workflow, so the feature details below matter more than the headline rank alone.

Updated

Direct Answer

Doximity ranks higher than Glass Health overall in our 2026 clinical AI evaluation: #4 with a 3.5/5 rating versus #5 with a 3.5/5 rating. Choose Doximity when the priority is the stronger all-around CDS score; choose based on the table below when your workflow depends on citations, drug data, calculators, EHR support, mobile access, or cost.

Source: Clinical AI Report, 2026

Feature Comparison

FeatureDoximityGlass Health
Rating
Good
Good
CategoryMedical Professional Network & AI ToolsAI Diagnostic Assistant
PricingFree (Ad-Supported)Free Beta / Enterprise Pricing TBD
Founded20102021
HeadquartersSan Francisco, CASan Francisco, CA
Evidence CitationsYesNo
AI Differential DiagnosisYesYes
Drug DatabaseYesNo
Drug Interaction CheckerNoNo
Medical CalculatorsNoNo
Natural Language SearchYesYes
Document & Image UploadYesNo
EHR IntegrationNoYes
Mobile AppYesNo
Built-in DialerYesNo
AI Clinical ScribeYesNo
CME CreditsYesNo
Multi-LanguageNoNo

Strengths & Limitations

Doximity

Strengths

  • +Largest physician network in the US (3M+ members, ~85% of US physicians)
  • +Ask is advertised as free for U.S. healthcare professionals; confirm account eligibility
  • +Pathway Medical acquisition adds 3,200+ peer-reviewed drug monographs
  • +PeerCheck physician review program (10,000+ medical experts, co-chaired by Eric Topol)
  • +Evidence-based clinical answers grounded in structured medical literature
  • +300,000+ clinicians actively using AI tools (Q3 FY2026)
  • +AI Scribe for ambient clinical documentation
  • +Secure HIPAA-compliant messaging and integrated telehealth
  • +100+ health system enterprise deployments

Limitations

  • –AI revenue not yet commercialized — long-term AI business model unproven
  • –Networking-heavy interface can be distracting for clinical use
  • –Pathway integration is recent (late 2025) — clinical depth still maturing
  • –Company-published preference study lacks independent peer review
  • –Revenue model relies on pharmaceutical and health system advertising
  • –Check current Ask availability and workflow fit for your device and institution

Glass Health

Strengths

  • +Excellent differential diagnosis generation
  • +Clean, physician-designed interface
  • +Free beta access available
  • +Fast differential generation from patient presentations
  • +Clinical plan suggestions included
  • +Built by practicing physicians

Limitations

  • –Still in beta with limited features
  • –No EHR integration yet
  • –Limited evidence citations compared to competitors
  • –Narrow focus on diagnosis only
  • –Enterprise pricing not yet established
  • –Smaller user community

Key Statistics

Doximity

PricingFree (Ad-Supported)(Doximity)
Founded2010(Doximity)
Users3M+ members (85% of US physicians); 300K+ AI users(Doximity Q3 FY2026 Earnings)
Key DifferentiatorLargest physician network + Pathway Medical AI acquisition(Doximity)
Editorial score70/100 (3.5/5) — weighted editorial assessment(Clinical AI Report scoring methodology)

Glass Health

PricingFree Beta / Enterprise Pricing TBD(Glass Health)
Founded2021(Glass Health)
UsersBeta users (growing)(Glass Health)
Key DifferentiatorAI differential diagnosis from patient presentations(Glass Health)
Editorial score69/100 (3.5/5) — weighted editorial assessment(Clinical AI Report scoring methodology)

Citable Summaries

Doximity

Doximity has an editorial score of 70/100 (3.5/5), calculated from Clinical AI Report's published criteria weights. It ranks #4 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.

Source: Clinical AI Report, May 2026

Glass Health

Glass Health has an editorial score of 69/100 (3.5/5), calculated from Clinical AI Report's published criteria weights. It ranks #5 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.

Source: Clinical AI Report, May 2026

Our Assessment

In our 2026 evaluation, Doximity (ranked #4, 3.5 stars) outperforms Glass Health (ranked #5, 3.5 stars) in overall physician satisfaction and editorial scoring. Doximity is best suited for physicians already embedded in the Doximity ecosystem who want AI-powered clinical answers, drug reference, and documentation without switching platforms. Especially relevant for practices with enterprise Doximity contracts. Meanwhile, Glass Health is a stronger choice for physicians and medical students who want a focused, free, AI-powered tool for generating differential diagnoses and clinical plans. Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.

Read Full Reviews

Also Compare